BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AZD4063 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AZD4063\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07241104-11158@assetmemo.bio
DTSTAMP:20261121T004542Z
DTSTART;VALUE=DATE:20271122
DTEND;VALUE=DATE:20271123
SUMMARY:AZD4063: Phase 1 readout est. (NCT07241104)
DESCRIPTION:AZD4063\, phase 1\, Dilated Cardiomyopathy.\nStudy: A Study of 
 AZD4063 in PLN R14del Dilated Cardiomyopathy\nEstimated primary completion
 : 22 November 2027. This is a ClinicalTrials.gov estimate\, not a confirme
 d readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/a
 zd4063#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/
 NCT07241104
URL:https://assetmemo.bio/drug/azd4063#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
